Jade Biosciences (JBIO) Interest Expenses (2021 - 2024)

Jade Biosciences posted quarterly Interest Expenses of $6000.0 for Q2 2024, up 500.0% year-on-year from $1000.0 in Q3 2023, and up 100.0% on a QoQ basis from $3000.0 in Q1 2024.

Jade Biosciences (JBIO) has 4 years of Interest Expenses data on file, last reported at $6000.0 in Q2 2024.

  • For the quarter ending Q2 2024, Interest Expenses rose 500.0% year-over-year to $6000.0; the trailing twelve-month figure through Mar 2025 stood at $6000.0 (up 50.0% YoY), and the FY2023 full-year result was $1000.0, down 98.73% from the prior year.
  • Interest Expenses for Q2 2024 stood at $6000.0, up from $3000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $6000.0 in Q2 2022 and bottomed at -$1000.0 in Q4 2021.
  • The 4-year median for Interest Expenses is $2000.0 (2021), against an average of $2500.0.
  • The widest annual swing landed in 2023, when Interest Expenses sank 83.33%; it then soared 500.0% in 2024.
  • A 4-year view of Interest Expenses shows it stood at -$1000.0 in 2021, then surged by 700.0% to $6000.0 in 2022, then tumbled by 83.33% to $1000.0 in 2023, then jumped by 500.0% to $6000.0 in 2024.
  • The last three Interest Expenses figures came in at $6000.0 (Q2 2024), $3000.0 (Q1 2024), and $1000.0 (Q2 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 22,854.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -5.50 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 61,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -332,000.00
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 12.90 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 69.29 Mn
10 Jade Biosciences 1.06 Bn 1.06 Bn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2024 6,000.00
Jun 30, 2024 6,000.00
Mar 31, 2024 3,000.00
Mar 31, 2024 3,000.00
Jun 30, 2023 1,000.00
Jun 30, 2023 1,000.00
Mar 31, 2023 1,000.00
Mar 31, 2023 1,000.00
Jun 30, 2022 6,000.00
Jun 30, 2022 6,000.00
Dec 31, 2021 -1,000.00
Dec 31, 2021 -1,000.00
Jun 30, 2021 3,000.00
Jun 30, 2021 3,000.00
Mar 31, 2021 1,000.00
Mar 31, 2021 1,000.00